What is Sanofi India Ltd's market cap?

Sanofi India Ltd (SANOFI) has a market capitalization of ₹7,351 Cr.

What sector is SANOFI in?

Sanofi India Ltd operates in the Pharmaceuticals — Formulations & API sector.

Loading company...

Analyzing...

Sanofi India Ltd (SANOFI) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Sanofi India Ltd

SANOFI|BSE: 500674

Pharmaceuticals — Formulations & APIHealthcare & Life Scienceswww.sanofiindialtd.com

—

—|MCap ₹7,351 Cr

Promoter: 60.4%

Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 3,530 full-time employees. The firm

Secular Currents

Theme Connections

Healthcare Access Pharma CDMO

Intelligence Profile

TSF Score

43/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

5Clean

Trust Score

X-Ray

Concerns

No significant concerns identified

Watch

Nothing flagged for monitoring

Strengths

🟢Low leverage (D/E: —)Business
🟢Consistent dividend payerOpportunity

The Numbers · Key Metrics

₹7,068 Cr

The Narrator · StoryTel Intelligence

FY2024Pharmaceuticals — Formulations & APIProduct Sales ModelModel:Revenue = Volume of Drugs Sold × Average Selling Price (Domestic + Export)

Key Insight

“Operates in Pharmaceuticals — Formulations & API.”

The Revenue Story

₹2,013 Cr revenue.

Total Income₹2,030 Cr

Revenue₹2,013 Cr(99.2% of Total Income)

Other Income₹17 Cr(0.8% of Total Income)

The Cost Story

COGS 48.6%, employees 11.9%.

Cogs₹979 Cr(47.4%)

EBITDA₹507 Cr(24.5%)

Other Expenses₹303 Cr(14.6%)

Employee₹240 Cr(11.6%)

Depreciation₹37 Cr(1.8%)

Finance Costs₹2 Cr(0.1%)

Cogs

47.4%

EBITDA

24.5%

Other Expenses

14.6%

Employee

11.6%

Depreciation

1.8%

Finance Costs

0.1%

Forward View · Management Guidance

GUIDANCEQ3FY26High Impact

“Without the replenishment issues at the partner level, the combined growth would have been significantly higher, potentially reaching double digits for the quarter.”

FINANCIALQ2FY26— 0High Impact

“Export is around 12-13% of total sales. Export drop significant in top line but only 8% impact on profit before tax”

FINANCIALQ2FY26— 2High Impact

“operating margin, we in this quarter are under 28%”

The Context · Where does it sit?

Sector Context

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Low Impact

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹2,235 Cr

PBT₹515 Cr

EPS₹179.45

(₹ Cr)	TTM	FY2024	FY2023
Revenue	₹2,235 Cr +11.0%	₹2,013 Cr -29.4%	₹2,851 Cr
Other Income	₹20 Cr +18.2%	₹17 Cr -74.7%	₹65 Cr
Total Income	₹2,254 Cr +11.1%	₹2,030 Cr -30.4%	₹2,916 Cr
COGS	₹1,039 Cr +6.1%	₹979 Cr -18.5%	₹1,201 Cr
	₹1,701 Cr +9.0%	₹1,561 Cr -25.3%	₹2,089 Cr
Profit Before Tax	₹515 Cr +19.4%	₹431 Cr -49.0%	₹846 Cr
Exceptional Items	(₹38 Cr) 0.0%	(₹38 Cr) ↓ Decline	₹18 Cr
	₹137 Cr +16.4%	₹118 Cr -51.5%	₹243 Cr
Net Profit	₹378 Cr +20.6%	₹314 Cr -48.0%	₹603 Cr
Profit (Owners)	₹413 Cr -0.0%	₹413 Cr -31.4%	₹603 Cr
Other Comprehensive Income	₹7 Cr 0.0%	₹7 Cr ↑ Recovery	(₹1 Cr)
EPS	₹179.45	₹179.46	₹261.78
Diluted Shares	₹2 Cr	₹2 Cr	₹2 Cr
Profit Loss From Discontinued Operations After Tax	₹35 Cr -64.9%	₹100 Cr	₹0.00 Cr